N
PFE icon

Nuveen’s Pfizer PFE Stock Holding History

Nuveen’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,800
Closed -$4K – 3393
2021
Q3 		$4K Buy
+100,800
New +$4.47M ﹤0.01% 3391

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Nuveen's PFE Position: Q1 2026 in Review

Nuveen increased its Pfizer (PFE) stake by 0.11% in Q1 2026, buying an estimated $386K and bringing the position to 13,178,661 shares worth $370M. The position accounts for 0.1% of the portfolio, ranked #163.

Nuveen first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.66B in Q4 2021. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Nuveen held 13,178,661 shares of Pfizer worth $370M as of Q1 2026.
  • Nuveen bought 14,511 Pfizer shares in Q1 2026, an estimated $386K.
  • Pfizer made up 0.1% of Nuveen's portfolio in Q1 2026, its #163 holding.
  • Nuveen first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Pfizer position peaked at $1.66B in Q4 2021.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.